1. Academic Validation
  2. Bcl2-L-10, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway

Bcl2-L-10, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway

  • Hum Mol Genet. 2001 Oct 1;10(21):2329-39. doi: 10.1093/hmg/10.21.2329.
H Zhang 1 W Holzgreve C De Geyter
Affiliations

Affiliation

  • 1 University Women's Hospital Basel, Schanzenstrasse 46, CH-4031 Basel, Switzerland. [email protected]
Abstract

By GenBank database searches and PCR, we have identified a novel human Bcl2-like gene, Bcl2-L-10, which contains conserved BH4, BH1 and BH2 domains but lacks BH3 domain. The Bcl2-L-10 gene has been assigned to chromosome 15q21.2. Transfection experiments demonstrated that Bcl2-L-10 can block Apoptosis induced by interleukin-3 withdrawal and Bax expression, by prevention of cytochrome C release, Caspase-3 activation and mitochondrial membrane potential collapse. Bcl2-L-10 cannot block TNFalpha-induced Apoptosis. Furthermore, both the BH4 domain and the transmembrane domain of Bcl2-L-10 are necessary for its suppressive action on cell death. Our results demonstrated that Bcl2-L-10 is a newly detected anti-apoptotic member of the Bcl-2 Family and that it blocks Apoptosis in the mitochondrial death pathway but not in the death receptor pathway.

Figures